Market Research Report
Gastroparesis Epidemiology Forecast - 2028
|Published by||DelveInsight Business Research LLP||Product code||524499|
|Published||Content info||100 Pages
Delivery time: 1-2 business days
|Gastroparesis Epidemiology Forecast - 2028|
|Published: December 1, 2019||Content info: 100 Pages||
DelveInsight's Gastroparesis Epidemiology Forecast to 2028 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Gastroparesis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Study Period: 2017-2028
Gastroparesis, which is a translated meaning of "stomach paralysis", is a digestive disorder characterized by delayed gastric emptying of solid food in the absence of mechanical obstruction of the stomach, resulting in the cardinal symptoms of early satiety, postprandial fullness, nausea, vomiting, belching and bloating. It is now recognized as part of a broader spectrum of gastric neuromuscular dysfunction that includes impaired gastric accommodation. The overlap between the symptoms, of Gastroparesis and other disorders such as functional dyspepsia, makes the diagnosis of Gastroparesis difficult.
Gastroparesis may be idiopathic or associated with diabetes mellitus, may occur after a medical intervention (iatrogenic or post-surgical), or with neurological disorders, it can also occur after a viral or bacterial infection, such as Salmonella gastroenteritis. Interestingly, Helicobacter pylori infection of the stomach does not seem to influence gastric emptying or accommodation but may be associated with heightened sensitivity in patients with functional dyspepsia.
"According to the American Diabetes Association, Gastroparesis is a disorder affecting people with both type 1 and type 2 diabetes, in which the stomach takes too long to empty its contents (delayed gastric emptying). The vagus nerve controls the movement of food through the digestive tract. If this nerve is damaged or stops working, the muscles of the stomach and intestines do not work normally, and the movement of food is slowed or stopped. Just as with other types of neuropathy, diabetes can damage the vagus nerve if blood glucose levels remain high over a long period. High blood glucose causes chemical changes in nerves and damages the blood vessels that carry oxygen and nutrients to the nerves."
The etiology of Gastroparesis include diabetic, postsurgical, Iatrogenic, surgical and idiopathic as these are major causes of gastroparesis. Based on the causes, Gastroparesis is divided into three major types, i.e., Idiopathic gastroparesis, Diabetic gastroparesis, and Post-surgical gastroparesis. Some of the researchers proposed a classification system to help determine appropriate treatment options such as Grade 1, or mild gastroparesis, is characterized by symptoms that come and go and can easily be controlled by dietary modification and by avoiding medications that slow gastric emptying. Grade 2, or compensated gastroparesis, is characterized by moderately severe symptoms.
DelveInsight's Gastroparesis epidemiology report gives a thorough understanding of the Gastroparesis by including details, such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends.
The Gastroparesis epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders (KOL). This part of the DelveInsight's report also provides the diagnosed patient pool and their trends along with undertaken assumptions.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented by Total Prevalence of Gastroparesis, Gender-Specific Prevalence of Gastroparesis, Severity-Specific Prevalence of Gastroparesis, Type-Specific Prevalence of Gastroparesis, and Total Diagnosed Prevalent Population of Gastroparesis] scenario of Gastroparesis in the 7MM Countries covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2017 to 2028.
DelveInsight's analysts have assessed that the total prevalent population of Gastroparesis in the 7MM was 33,690,400 in 2017. Additionally, it was accessed that the total diagnosed prevalent population of Gastroparesis in the 7MM was assessed to be 16,845,200 in 2017. DelveInsight's estimate suggests that the United States witnessed the highest number of cases with Gastroparesis, as compared to other 7MM countries. As per DelveInsight's estimates, the country accounted for approximately 13,019,321 cases in 2017. Among the European 5 countries, Germany had the highest prevalent population of Gastroparesis, followed by Spain and Italy. On the other hand, the United Kingdom had the lowest prevalent population of Gastroparesis in 2017. Furthermore, Japan had 5,785,669 prevalent cases for Gastroparesis in 2017. As per DelveInsight's analysis, a higher percentage of diagnosed prevalence of Gastroparesis was observed for females, in comparison to males, in all the 7MM countries.